FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Drug Interaction Studies Draft Guide

Federal Register notice: FDA makes available a draft guidance entitled M12 Drug Interaction Studies.

latest-news-card-1
Federal Register

Info Collection on User Fee Review Transparency

Federal Register notice: FDA sends to OMB an information collection revision entitled Review Transparency and Communication for New Molecular Entity N...

latest-news-card-1
Federal Register

FDA Issues EUA for Covid Test, Revokes 4 Others

Federal Register notice: FDA announces the issuance of one, and revocation of four Emergency Use Authorizations issued to STS Lab Holdco (a subsidiary...

latest-news-card-1
Biologics

Moderna Files Patent Suit Against Pfizer/BioNTech

Moderna files a patent infringement lawsuit against Pfizer/BioNTech in Massachusetts federal court over their Comirnaty Covid-19 vaccine.

latest-news-card-1
Human Drugs

2 ICH Guidances on Drug Analytical Procedures

FDA makes available two International Council for Harmonization draft guidances on drug analytical procedures.

latest-news-card-1
Medical Devices

FDA Removes N95 Respirators from Shortages List

FDA removes N95 respirators from its medical device shortage list, which it says signals that demand or projected demand for this type of face protect...

latest-news-card-1
Human Drugs

ICH Guide on Evaluating QT/QTc Interval Prolongation

FDA releases a final guidance entitled E14 and S7B Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential Qu...

latest-news-card-1
Medical Devices

Integra LifeSciences Removes CereLink Intracranial Monitors

Integra LifeSciences begins a global product removal of all CereLink intracranial pressure monitors after customer reports were received about devices...

latest-news-card-1
Human Drugs

Incytes Pemazyre OKd for Rare Blood Cancer

FDA approves an Incyte supplemental NDA for Pemazyre (pemigatinib), a selective fibroblast growth factor receptor inhibitor for treating adults with c...

latest-news-card-1
Medical Devices

Medtronic HVAD Battery Recall is Class 1

FDA says the Medtronic recall of HVAD batteries for electrical faults is Class 1.